4Keck P Jr,Buffenstein A,Ferguson J,et al.Ziprasidone 40 and 20 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder:a 4-week placebo controlledtrial[J].Psychopharmacology,1998,140:173.
二级参考文献42
1Harvey PD, Bowie CR. Ziprasidone: efficacy, tolerability, and emerging data on wide-ranging effectiveness [J].Expert Opin Pharmacother,2005,6(2): 337
2Stip E, Chouinard S, Boulay LJ. On the trail of a cognitive enhancer for the treatment of schizophrenia [ J]. Prog Neuropsychopharmacol Biol Psychiatry, 2005,29 (2) : 219
3Csernansky JG, Mahmoud R, Brenner R. A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia[ J]. N Engl J Med , 2002,346:16.
4Markianos M, Hatzimanolis J, Lykouras L. Neuroendocrine responsivities of the pituitary dopamine system in male schizophrenic patients during treatment with clozapine, olanzapine,ri speridone, sulpiride, or haloperidol[ J]. Eur Arch Psychiatry Clin Neurosci ,2001,251: 141.
5Keck P Jr, Buffenstein A, Ferguson J, et al. Ziprasidone 40and 20 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 4 - week placebo controlled trial [J]. Psychopharmacology, 1998,140:173.
6Goff DC, Posever T, Herz L, et al. An exploratory haloperidol - controlled dose finding study of ziprasidone in hospitalized patients with schizophrenia or schizoaffective disorde [ J ]. J Clin Psychopharmacol , 1998,18:296.
7Pezawas L, Quiner S, Moertl D, et al. Efficacy, cardiac safety and tolerability of sertindole:a drug surveillance [J]. Int Clin Psychopharmacol,2000,15 :207 .
8Van Kammen DP, McEvoy JP, Targum SD, et al. A randomized, controlled, dose - ranging trial of sertindole in patients with schizophrenia[J]. Psychopharmacolog y, 1996,124:168.
9Zimbroff DL, Kane JM, Tamminga CA, et al. Controlled,dose - response study of sertindole and haloperidol in the treatment of schizophrenia[ J]. Am J Psychiatry, 1997,154:782.
10Peuskens J, Bech P, Moller H J, et al. Amisulpride vs. risperidone in the treatment of acute exacerbations of schizophrenia [ J ]. Psychiatry Res, 1999,88 ( 2 ): 107.
5Addington D, Addington J, Schissel B. A depression rating scale for schizophrenics [ J ]. Schizophr Res, 1990,3 (4) :247-251.
6Addington D, Addington J, Maticka-Tyndale E. Specificity of the Calgary Depression Scale for schizophrenics. [J]. Schizophr Res, 1994, 11(3) : 239 -244.
7Koreen AR, Sifts SG, Chakos M, et al. Depression in firstepisode schizophrenia[J]. Am J Psychiatry, 1993, 150( 11 ) : 1643-1648.
8Weiden P J, Daniel DG, Simpson G, et al. hnprovement in indices of health status in outpatients with schizophrenia switched to ziprasidone [ J ]. J Clin Psychopharmacol, 2003,23 (6) :595 -600.
9Kinon B J, Lipkovich I, Edwards SB, et al. A 24-week randomized study of olanzapine versus ziprasidone in the treatment of schizophrenia or schizoaffective disorder in patients with prominent depressive symptoms [ J ]. J Clin. Psyehopharmaeo1,2006,26 (2) : 157-162.
